*Types of therapists concerned: - Occupational therapists, physical therapists, speech therapists, psychologists *The goal of the training: understanding the psychomotor system and psychomotor disorders, their impact on patients, being able to perform a psychomotor evaluation, and create a therapy plan adapted to each patient. *Duration: 15 to 25 days (5-day modules). *3 specific specialities: -Paediatrics -Adult mental health -Geriatrics
Visit ID (prod)
ISRPR.N14Founded in 1967, Institut Supérieur de Rééducation Psychomotrice (ISRP) – Higher Institute of Psychomotor Therapy is the brainchild of Giselle Soubiran in collaboration with her son, José Soubiran.Giselle developed the concept of psychomotor therapy (PMT) as a proper rehabilitation therapy in the 1950s, then the PMT institute was established at 1967.Today, ISRP is the largest PMT school in the world, with three campuses in France, located in Paris, Marseille, and Vichy. The Institute has been in operation for over 50 years and has successfully trained over 7,000 psychomotor therapists in France. ISRP has two centers of continuos education and training in China and the United Arab Emirates.Psychomotor Therapy (PMT) applies to various pathologies for individuals within different age groups, from infants to the elderly. Some of the most common conditions treated with the help of PMT rehabilitation techniques include:- Paediatrics and adolescent:*Conditions affecting premature babies, disorders in infants and children.*Neurodevelopmental disorders Attention deficit hyperactivity disorder (ADHD)/learning disabilities, Autism, Down’s Syndrome, Cerebral palsy.*Teen depression and other conditions: Addiction, Eating disorders.-Adults:*Mild mental illnesses: Stress, Anxiety, Depression.*Workplace disorders: Psychosocial risks and Burnouts.*Severe mental illnesses: Paranoia, Schizophrenia, Biploar syndrome.*Psychotrauma.*Other neurological conditions: Stroke, Cognitive disorders, Multiple sclerosis.-Elderly:*Prevention and management of neurodegenerative disorders Parkinson’s disease, Alzheimer’s disease.